Valuation Coral Laboratories Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:12:45 2026-07-28 EDT			5-day change	1st Jan Change
576.75 ^INR	+3.70%		-1.91%	+31.53%

05-30	Coral Laboratories Limited Recommends Final Dividend for the Financial Year 2025-2026	CI
05-30	Coral Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	350.1	1,151	912.1	817.8	1,327	2,506
Change	-	228.83%	-20.78%	-10.34%	62.25%	88.85%
Enterprise Value (EV) ¹	398.1	1,191	729.8	517.7	1,049	2,232
Change	-	199.05%	-38.7%	-29.07%	102.64%	112.77%
P/E	4.91x	8.49x	10.1x	12.7x	8.4x	10.4x
PBR	0.3x	0.84x	0.58x	0.53x	0.75x	1.25x
PEG	-	0.1x	-0.3x	-0.4x	0x	0.2x
Capitalization / Revenue	0.5x	1.19x	1.21x	1.05x	1.59x	2.18x
EV / Revenue	0.56x	1.23x	0.97x	0.66x	1.25x	1.94x
EV / EBITDA	6.98x	7.33x	8.51x	12.2x	6.33x	8.39x
EV / EBIT	10.7x	8.34x	11.1x	25x	7.18x	9.07x
EV / FCF	-4.65x	-62.2x	-107x	7.71x	-11.2x	-25.8x
FCF Yield	-21.5%	-1.61%	-0.93%	13%	-8.94%	-3.88%
Dividend per Share ²	-	-	-	-	2	1.5
Rate of return	-	-	-	-	0.54%	0.21%
EPS ²	19.96	37.94	25.32	18.04	44.19	67.61
Distribution rate	-	-	-	-	4.53%	2.22%
Net sales ¹	705.8	965.7	756.1	781.2	836.6	1,150
EBITDA ¹	57	162.5	85.74	42.45	165.8	265.9
EBIT ¹	37.12	142.8	65.97	20.73	146.1	246
Net income ¹	71.3	135.5	90.46	64.45	157.9	241.6
Net Debt ¹	48.01	39.3	-182.3	-300.1	-277.9	-273.9
Reference price ²	98.00	322.25	255.30	228.90	371.40	701.40
Nbr of stocks (in thousands)	3,573	3,573	3,573	3,573	3,573	3,573
Announcement Date	8/20/20	9/1/21	9/6/22	7/18/23	9/5/24	9/3/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CORAL LABORATORIES LIMITED	-	-	-	-	20.72M
ELI LILLY AND COMPANY	35.56x	12.7x	26.67x	0.56%	1,068B
JOHNSON & JOHNSON	28.51x	6.52x	18.04x	2.02%	641B
ABBVIE INC.	32.33x	7.59x	15.6x	2.68%	454B
ROCHE HOLDING AG	19.49x	4.75x	11.79x	2.78%	351B
NOVARTIS AG	22.29x	5.76x	14.37x	2.78%	299B
ASTRAZENECA PLC	21.47x	4.5x	12.72x	1.93%	266B
NOVO NORDISK A/S	14.4x	5.35x	11.02x	3.48%	220B
AMGEN INC.	24.71x	6.49x	11.44x	2.68%	203B
GILEAD SCIENCES, INC.	-47.03x	5.64x	31.15x	2.53%	162B
Average	16.86x	6.59x	16.98x	2.38%	366.34B
Weighted average by Cap.	24.76x	7.96x	18.76x	1.95%